Merck | MRK - Cash And Equivalent

Stock Price
107.35
Daily Change
-2.45 -2.23%
Monthly
-0.28%
Yearly
-7.46%
Q2 Forecast
106.58

Merck reported EUR2.25B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Adidas EUR 1.62B 587M Dec/2025
Adyen EUR 12.42B 2.45B Jun/2025
Akzo Nobel EUR 1.55B 47M Jun/2025
Alcon AG USD 1.5B 90M Sep/2025
Amadeus IT EUR 968.2M 525.2M Sep/2025
Amarin USD 122.8M 25.08M Sep/2025
AstraZeneca USD 8.14B 1.08B Sep/2025
BASF EUR 2.67B 811M Dec/2025
Bayer EUR 5.9B 1.34B Sep/2025
Beiersdorf EUR 1.17B 40M Jun/2025
Covestro EUR 604M 115M Sep/2025
Danone EUR 1.98B 364M Dec/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
Galapagos EUR 87.87M 23.41M Dec/2025
Genmab DKK 1.72B 46M Dec/2025
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.3B 303M Sep/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Infineon EUR 1.24B 120M Dec/2025
Linde USD 5.06B 547M Dec/2025
Lonza CHF 719M 188M Dec/2025
Merck EUR 2.25B 1.08B Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
Philips EUR 1.91B 90M Sep/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
UCB EUR 1.57B 1.14B Dec/2024